NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹6,247 Cr | ₹4,466 Cr | ₹3,292 Cr | ₹2,667 Cr | ₹2,568 Cr |
What is the latest Profit & Loss Account Balance ratio of NATCO PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹6,247 Cr |
| Mar2024 | ₹4,466 Cr |
| Mar2023 | ₹3,292 Cr |
| Mar2022 | ₹2,667 Cr |
| Mar2021 | ₹2,568 Cr |
How is Profit & Loss Account Balance of NATCO PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,247 Cr | 39.88 | |
| Mar2024 | ₹4,466 Cr | 35.64 | |
| Mar2023 | ₹3,292 Cr | 23.46 | |
| Mar2022 | ₹2,667 Cr | 3.83 | |
| Mar2021 | ₹2,568 Cr | - | |
Compare Profit & Loss Account Balance of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,993.9 Cr | 6% | 12.5% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,343.0 Cr | -0.2% | 5.8% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,774.0 Cr | -0.6% | -5.2% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,665.0 Cr | -0.5% | 2.5% | 12.1% | Stock Analytics | |
| CIPLA | ₹122,878.0 Cr | -1.1% | -0.2% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,581.0 Cr | 2.4% | 7% | 6.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 6% |
12.5% |
-32.1% |
| SENSEX | -0.5% |
1.5% |
6.9% |
You may also like the below Video Courses